glycycoumarin and Non-alcoholic-Fatty-Liver-Disease

Herbal medicine as an alternative approach in the treatment of disease has drawn growing attention. Identification of the active ingredient is needed for effective utilization of the herbal medicine. Licorice is a popular herbal plant that is widely used to treat various diseases including liver diseases. Glycycoumarin (GCM) is a representative of courmarin compounds isolated from licorice. In the present study, the protective effect of GCM on hepatocyte lipoapoptosis has been evaluated using both cell culture model of palmitate-induced lipoapoptosis and animal model of non-alcoholic steatohepatitis (NASH). The results demonstrated for the first time that GCM was highly effective in suppressing hepatocyte lipoapoptosis in both in vitro and in vivo. Mechanistically, GCM was able to re-activate the impaired autophagy by lipid metabolic disorders. In line with the activation of autophagy, ER stress-mediated JNK and mitochondrial apoptotic pathway activation was inhibited by GCM both in vitro and in vivo. In addition, inactivation of GSK-3 might also contribute to the protective effect of GCM on hepatocyte lipoapoptosis. Our findings supported GCM as a novel active component of licorice against non-alcoholic fatty liver disease (NAFLD).

Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cell Line, Tumor; Coumarins; Endoplasmic Reticulum Stress; Glycogen Synthase Kinase 3; Glycyrrhiza; Hep G2 Cells; Hepatocytes; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease